| Intangible Assets Disclosure [Text Block] |
The carrying amount and accumulated amortization of intangible assets consisted of the following (in thousands):
| |
|
March 31, 2021 |
|
|
December 31, 2020 |
|
| |
|
Gross Assets |
|
|
Accumulated Amortization |
|
|
Net |
|
|
Gross Assets |
|
|
Accumulated Amortization |
|
|
Net |
|
| Nonamortizable intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade names |
|
$ |
2,000 |
|
|
$ |
- |
|
|
$ |
2,000 |
|
|
$ |
2,000 |
|
|
$ |
- |
|
|
$ |
2,000 |
|
| Amortizable intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade names |
|
|
23 |
|
|
|
(23 |
) |
|
|
- |
|
|
|
23 |
|
|
|
(23 |
) |
|
|
- |
|
| Physician and customer relationships |
|
|
36,534 |
|
|
|
(29,518 |
) |
|
|
7,016 |
|
|
|
36,534 |
|
|
|
(28,924 |
) |
|
|
7,610 |
|
| Software |
|
|
11,230 |
|
|
|
(10,083 |
) |
|
|
1,147 |
|
|
|
11,230 |
|
|
|
(9,663 |
) |
|
|
1,567 |
|
| Acquisition - FilAMed |
|
|
1,186 |
|
|
|
(28 |
) |
|
|
1,158 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total nonamortizable and amortizable intangible assets |
|
$ |
50,973 |
|
|
$ |
(39,652 |
) |
|
$ |
11,321 |
|
|
$ |
49,787 |
|
|
$ |
(38,610 |
) |
|
$ |
11,177 |
|
Amortization expense for the three months ended March 31, 2021 was $1.0 million, compared to $1.1 million for the same prior year period, which was recorded in operating expenses. Expected annual amortization expense for the next five years for intangible assets recorded as of March 31, 2021 is as follows (in thousands):
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2026 and |
|
|
|
|
|
| |
|
2021 |
|
|
2022 |
|
|
2023 |
|
|
2024 |
|
|
2025 |
|
|
thereafter |
|
|
Total |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amortization expense |
|
$ |
3,043 |
|
|
$ |
2,221 |
|
|
$ |
717 |
|
|
$ |
717 |
|
|
$ |
537 |
|
|
$ |
2,086 |
|
|
$ |
9,321 |
|
|